In this study, we find that silencing the expression of the splicing factor SNRPB decreased POLD1 expression levels in endometrial cancer cells, and POLD1 was identified as a critical downstream target of SNRPB in endometrial cancer cells. This evidence concerns the gene POLD1 and endometrial cancer.